Read more: Evidation, USC and RAND awarded NIH R01 Research Project Grant to develop a representative digital health dataset and novel data science methods

← Back to news

Menlo Park, CA & San Francisco, CA—September 22, 2015 Today CrowdMed and Evidation Health announce the completion of a digital health study investigating the clinical and economic impact of using CrowdMed to diagnose complex medical cases online. CrowdMed selected Evidation Health to design and execute the study utilizing novel technology to compare healthcare utilization pre-and post-case resolution in CrowdMed patients.

Evidation Health leveraged its medical data partnerships to seamlessly access claims data from a range of insurers for the patients enrolled virtually in the study. After patients provided consent for data access, Evidation Health automatically retrieved and de-identified claims data and analyzed results using the company’s secure, HIPAA-compliant research platform.

Evidation Health, a company launched by GE Ventures and Stanford Health Care, is focused on quantifying the health outcomes of digital health solutions and leveraging digital tools to more efficiently generate real-world evidence. “The CrowdMed study has been an exciting opportunity for us to deploy our unique research platform and health outcomes research services to generate evidence of clinical and economic utility for a truly novel approach to complex case diagnosis. This is a great example of executing on our mission to quantify outcomes of digital health solutions,” said Evidation Health CEO Deborah Kilpatrick.

CrowdMed is harnessing “the wisdom of crowds” to diagnose difficult medical cases online, in a fraction of the time and cost typical of cases resolved in the traditional medical system. CrowdMed has reportedly resolved over 1,000 real-world medical mysteries to-date, with an over 60% success rate.

“Evidation Health has enabled us to robustly quantify the positive impact CrowdMed can have in difficult medical cases, as a compelling complement to the anecdotal evidence we hear regularly from our customers,” said Jared Heyman, Founder and CEO of CrowdMed.

About Evidation Health

Evidation Health began as a collaboration between GE Ventures and Stanford Health Care to realize a shared vision for a digital health-enabled future. The company partners across the healthcare ecosystem to generate real-world clinical and economic evidence enabled by digital health solutions. Evidation Health helps partners quantify and optimize health outcomes through advanced analytics of medical, behavioral and contextual data at the patient-consumer level. Evidation Health is based in Menlo Park, CA. For more information, go to

About CrowdMed

CrowdMed is an innovative healthcare startup harnessing the wisdom of crowds to help solve complicated medical cases more quickly and efficiently. The company offers individuals, insurance providers, and self-insured corporate customers the ability to reduce their healthcare costs without compromising care. Founded by veteran technology entrepreneur Jared Heyman and based in San Francisco, CA, CrowdMed has received more than $2.4 million in funding from some of Silicon Valley’s top venture capital firms including NEA, Andreessen Horowitz, Greylock Partners, SV Angel, Khosla Ventures and Y Combinator. The company’s advisors have founded and run some the world’s most successful online healthcare companies including WebMD. CrowdMed graduated from Y Combinator’s Winter 2013 class, and was officially launched during the TEDMED 2013 conference in Washington DC. Visit for more information.


Evidation Health
Polly Israni

Jared Heyman

Further reading